Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001171843-14-002882
Filing Date
2014-06-18
Accepted
2014-06-18 07:00:21
Documents
2
Period of Report
2014-06-18

Document Format Files

Seq Description Document Type Size
1 FORM 6-K FILING DOCUMENT document.htm 6-K 3651
2 PRESS RELEASE newsrelease.htm EX-99 6206
  Complete submission text file 0001171843-14-002882.txt   10802
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 14926686
SIC: 2834 Pharmaceutical Preparations